BIOMAT Database Logo BIOMAT Database Logo

[Treatment of progressive chronic polyarthritis with a new cytostatic agent, Imet 3393]. 1971

G Wessel, and M Rübesamen, and P Hesse

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011687 Purines A series of heterocyclic compounds that are variously substituted in nature and are known also as purine bases. They include ADENINE and GUANINE, constituents of nucleic acids, as well as many alkaloids such as CAFFEINE and THEOPHYLLINE. Uric acid is the metabolic end product of purine metabolism.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D001562 Benzimidazoles Compounds with a BENZENE fused to IMIDAZOLES.
D014717 Vertigo An illusion of movement, either of the external world revolving around the individual or of the individual revolving in space. Vertigo may be associated with disorders of the inner ear (EAR, INNER); VESTIBULAR NERVE; BRAINSTEM; or CEREBRAL CORTEX. Lesions in the TEMPORAL LOBE and PARIETAL LOBE may be associated with FOCAL SEIZURES that may feature vertigo as an ictal manifestation. (From Adams et al., Principles of Neurology, 6th ed, pp300-1) CNS Origin Vertigo,Central Nervous System Origin Vertigo,Positional Vertigo,Spinning Sensation,Vertigo, Brain Stem,Vertigo, Brainstem,Vertigo, Central Nervous System Origin,Vertigo, Central Origin,Vertigo, Constant,Vertigo, Essential,Vertigo, Intermittant,Vertigo, Paroxysmal,Vertigo, Peripheral,Vertigo, Subjective,Brain Stem Vertigo,Brain Stem Vertigos,Brainstem Vertigo,Brainstem Vertigos,CNS Origin Vertigos,Central Origin Vertigo,Central Origin Vertigos,Constant Vertigo,Constant Vertigos,Essential Vertigo,Essential Vertigos,Intermittant Vertigo,Intermittant Vertigos,Origin Vertigo, CNS,Origin Vertigo, Central,Origin Vertigos, CNS,Origin Vertigos, Central,Paroxysmal Vertigo,Paroxysmal Vertigos,Peripheral Vertigo,Peripheral Vertigos,Sensation, Spinning,Sensations, Spinning,Spinning Sensations,Subjective Vertigo,Subjective Vertigos,Vertigo, CNS Origin,Vertigo, Positional,Vertigos,Vertigos, Brain Stem,Vertigos, Brainstem,Vertigos, CNS Origin,Vertigos, Central Origin,Vertigos, Constant,Vertigos, Essential,Vertigos, Intermittant,Vertigos, Paroxysmal,Vertigos, Peripheral,Vertigos, Subjective

Related Publications

G Wessel, and M Rübesamen, and P Hesse
[Therapy of progressive chronic polyarthritis with cytostatic agents].
March 1968, Wiener klinische Wochenschrift,
G Wessel, and M Rübesamen, and P Hesse
[Treatment of primary chronic polyarthritis with a cytostatic agent of the ethyleneimine group].
January 1970, Zeitschrift fur Rheumaforschung,
G Wessel, and M Rübesamen, and P Hesse
[Intra-articular treatment of progressive chronic polyarthritis with cytostatic agents (thio-tepa)].
May 1966, Helvetica medica acta. Supplementum,
G Wessel, and M Rübesamen, and P Hesse
Investigation of cross-link formation in DNA by the alkylating cytostatic IMET 3106, 3393 and 3943.
December 1972, Biochimica et biophysica acta,
G Wessel, and M Rübesamen, and P Hesse
[Studies on therapy of rheumatoid arthritis (progressive chronic polyarthritis) with cytostatic drugs].
January 1969, Zeitschrift fur Rheumaforschung,
G Wessel, and M Rübesamen, and P Hesse
[Clinical experience report on the use of a new cytostatic 3393].
April 1968, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
G Wessel, and M Rübesamen, and P Hesse
[Treatment of progressive chronic polyarthritis with a non-steroidal antirheumatic agent with a long half-life].
May 1979, Fortschritte der Medizin,
G Wessel, and M Rübesamen, and P Hesse
[Treatment of progressive chronic polyarthritis].
December 1954, Vie medicale (Paris, France : 1920),
G Wessel, and M Rübesamen, and P Hesse
[Immunosuppressive treatment of progressive chronic polyarthritis].
August 1975, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
G Wessel, and M Rübesamen, and P Hesse
[Modern treatment of progressive chronic polyarthritis].
May 1973, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
Copied contents to your clipboard!